Video Experimental Relacionado
Updated: Jun 19, 2026
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Complicaciones cardiovasculares de la terapia contra el cáncer: diagnóstico, patogénesis y tratamiento
Edward T H Yeh1, Ann T Tong, Daniel J Lenihan
1Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Tex 77030-4095, USA. etyeh@mdanderson.org
Circulation
|July 1, 2004
Resumen
Los medicamentos anticancerígenos pueden causar cardiotoxicidad, lo que afecta a los pacientes con cáncer. La comprensión de los factores de riesgo y el desarrollo de estrategias de gestión son cruciales para la seguridad del paciente y el tratamiento eficaz del cáncer.
Área de la Ciencia:
- Oncología Oncología.
- Cardiología Cardiología.
- Farmacología Farmacología.
Sus antecedentes:
- La cardiotoxicidad es una complicación significativa de los tratamientos contra el cáncer.
- La gravedad de la cardiotoxicidad está influenciada por las propiedades del fármaco, los factores del paciente y el historial de tratamiento.
Objetivo del estudio:
- Revisar los agentes de quimioterapia de uso común y los recién aprobados en cuanto a su potencial cardiotoxicidad.
- Para resaltar la necesidad de más investigación en la predicción y el manejo de la cardiotoxicidad inducida por la quimioterapia.
Principales métodos:
- Revisión de la literatura sobre agentes quimioterapéuticos y sus efectos cardiotóxicos.
- Análisis de los factores que influyen en la cardiotoxicidad, incluida la dosis, la administración y las comorbilidades del paciente.
Principales resultados:
- Los agentes de quimioterapia, incluidas las aprobaciones recientes, poseen diferentes propensiones a la cardiotoxicidad.
- Los efectos cardiotóxicos pueden manifestarse de forma aguda o ser retrasados, apareciendo meses o años después del tratamiento.
Conclusiones:
- La predicción precisa del riesgo del paciente para la cardiotoxicidad requiere más investigación.
- El desarrollo de estrategias efectivas de gestión y reducción de riesgos para la cardiotoxicidad es esencial.
Videos de Conceptos Relacionados
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...